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1. General methods 
 
1.1. Synthesis 
All starting materials and reagents were commercial, unless otherwise indicated, and 
used without further purifications. Common solvents were dried and distilled by 
standard procedures. Flash chromatography was performed using silica gel (230-400 
mesh). NMR spectra were recorded using CDCl3 at 20 ºC. 1H NMR and 13C NMR 
chemical shifts () were referenced to internal solvent CDCl3 ( = 7.260 and 77.03 
ppm, respectively). DEPT 135 experiments were used to determine the type of 
carbon nucleus (C vs. CH vs. CH2 vs. CH3). FTIR spectra were obtained from neat 
samples using the ATR technique. High resolution mass spectrometry (HRMS) were 
performed using the EI technique. 
 
1.2. Fundamental optical properties 
Photophysical properties were registered in diluted solutions (ca. 1x10-5 M), prepared 
by diluting a concentrated stock solution in ethyl acetate. UV-Vis absorption and 
fluorescence spectra were recorded on a Bio-Tek spectrophotometer (model 
UVIKON XL) and a Sim-Aminco spectrofluorimeter (model Aminco Bowman Series 2), 
respectively. The fluorescence spectra were corrected from the wavelength 
dependence of de detector sensitivity. Commercial PM546 (1,3,5,7,8-penta-
methylBODIPY) was used as the reference dye (= 0.85 in ethyl acetate)1. 
 
1.3. Photostability  
Photostability was evaluated by pumping transversely 10 L of a dye solution in ethyl 
acetate (10-3 M) at 355 nm, with 4-mJ 8-ns FWHM pulses from the third-harmonic of 
a Q-switched Nd:YAG laser (Spectron SL282G), at a repetition rate of up to 10 Hz. 
The solutions were contained in a cylindrical Pyrex tube (1-cm height, 1-mm internal 
diameter) carefully sealed to avoid solvent evaporation during the experiments. The 
laser exciting pulses were line-focused onto the tube, providing pump fluences on the 
active medium in the range 110-180 mJ/cm2. The fluorescence emission was 
monitored perpendicular to the exciting beam, collected by an optical fiber, imaged 
onto the input slit of a monochromator (Acton Research corporation) and detected 




repeated at least three times. The estimated error in the energy and photostability 
measurements is 10%. 
 
1.4. Cell cultures 
HeLa (ATCC® CCL-2™) and Hs68 (ATCC® CRL-1635™) cells were grown as 
monolayer cultures in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented 
with 10% (v/v) fetal bovine serum (FBS), 50 U·mL-1 penicillin and 50 μg·mL-1 
streptomycin. All products were purchased from Thermo Fisher Scientific (Waltham, 
MA, USA) and sterilized by means of 0.22 μm filters (Merck Millipore, Billerica, MA, 
USA). Cell cultures were performed in a 5% CO2 atmosphere plus 95% air at 37 °C, 
and maintained in a SteriCult 200 (Hucoa-Erloss, Madrid, Spain) incubator. 
Subconfluent cell cultures seeded in 24-well plates (with or without coverslip, 
depending on the experiment) were used to perform the experiments. All sterile 
plastics were purchased from Corning (New York, NY, USA). 
 
1.5. Evaluation of the PDT activity 
After incubation with the corresponding dye (1-10 µM) during 24 h, cells were 
washed 3 times with culture medium and irradiated with 10.3 J/cm2 of green light 
(518 ± 10 nm). After irradiation, cells were maintained protected from light in the 
incubator for 24 h. Then, cell viability was evaluated by MTT [3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide] assay.  
For conducting the MTT assay, cells were incubated with 50 μg·mL-1 solution of MTT 
(Sigma Aldrich) in culture medium (from an initial MTT stock of 1 mg·mL-1 in PBS) for 
3 h. Then, generated formazan was extracted with 500 μL dimethyl sulfoxide 
(DMSO), and absorbance was measured at 542 nm in a SpectraFluor 
spectrophotometer (Tecan Group Ltd, Männedorf, Switzerland). Cell survival was 
expressed as the percentage of absorption of treated cells in comparison with that of 
control cells. Statistical significance for surviving-fraction data acquired from the 
conducted MTT assays is obtained by using one-way ANOVA (all groups vs. control 
group) Statistically significant differences are labelled as * (p < 0.001). DMSO in dyes 
solutions (up to 0.2% in the 10 μM solution) was checked to have no influence on cell 






1.6. Localization experiments 
Two experimental incubation conditions were selected to analyze the subcellular 
localization of the studied BODIPY dyes by fluorescence microscopy: (1) incubation 
with 5 μM dye for 24 h; (2) incubation with 75 nM dye for 1 h. Dye solution in culture 
medium was prepared from an initial 5 mM dye stock-solution in DMSO (Panreac, 
Barcelona, Spain). After incubating with the corresponding dye, cells were washed 
three times with PBS and observed by confocal or epifluorescence microscopy. 
To promote massive LD accumulation into the cells, cells were incubated with fresh 
sunflower-oil emulsion prior to their incubation with the corresponding dye. The said 
oil emulsion was prepared as reported by Stockert et al.2. Thus, commercial 
sunflower oil and DMEM were mixed in 1:1 v/v ratio and filtered through 0.45 μm filter 
(Merck Millipore, Billerica, MA, USA). The obtained oil emulsion was mixed with the 
culture medium in 1:6 v/v ratio, and incubated for 18 h prior to the incubation with the 
corresponding dye. 
To localize lysosomes in HeLa cells, acidic compartments of HeLa cells were labeled 
with LysoTracker® Red DND-99 (50 nM, ThermoFisher, USA) in the culture medium 
at 37 °C for 30 min. After labeling, cells were washed with PBS and observed by 
fluorescence microscopy. 
To localize mitochondria in HeLa cells, these organelles were labeled with 
MitoTracker® Green (200 nM, ThermoFisher, USA) in the culture medium at 37 °C 
for 30 min. After labeling, cells were washed with PBS and observed by fluorescence 
microscopy. 
To localize lipid droplets (LDs) in HeLa cell, lipids were stained with Oil Red O 
(ORO).3 For this purpose, the Lipir (Oil Red O) Staining Kit (K580-24, BioVision, San 
Francisco, CA, USA) was used following the kit instructions. The cells were observed 
by under-bright-field microscopy and fluorescence microscopy. 
 
1.7. Detection of ROS participation 
Intracellular ROS levels after photodynamic treatments were determined using 2´,7´-
dichlorodihydrofluorescein diacetate (DCFH-DA) as fluorogenic probe.4 Thus, 1 h 
after incubation with the corresponding dye, or after incubation and subsequent 
irradiation, cells were incubated with DCFH-DA 5 µM for 30 min, washed and 





Participation of 1O2 in the PDT acticivity was determined by quenching such ROS 
with sodium azide (NaN3).5 For this purposse, NaN3 (5 mM) was added to the cell-
culture 2 h prior to irradiation (PDT treatment), and the cytotoxicity evaluated by MTT 
assay 24 h after treatment and compared with paralell experiment without addind the 
quenceher.  
 
1.8. Characterization of cell-death mechanisms 
Apoptosis was identified by morphological criteria under light microscopy (phase 
contrast or differential interference contrast, DIC),6 as well as by indirect 
immunofluorescence detection of Cytochrome c or Caspase-3 activated proteins.7 
For this purpose, HeLa cells on coverslips were fixed in 4% PFA for 20 min at 4 °C, 
washed three times with PBS (5 min each), and permeabilized with 0.5% Triton X-
100. After 5 min, Triton X-100 was removed and cells were incubated in blocking 
solution (5% bovine serum albumin, 5% FBS, 0.02% Triton X-100 in PBS) for 30 min 
at RT. Once removed from blocking solution, 25 μl of a 1:50 solution of primary 
antibody (monoclonal mouse anti-cytochrome c; Santa Cruz Biotechnology, Santa 
Cruz, CA, USA) was added to each sample and incubated at 37 °C for 1 h. Three 5-
min washings with PBS were then carried out before addition of Triton X-100 for 
5 min. Incubation of secondary antibody (1:100 Fab specific goat anti-mouse IgG 
Alexa Fluor 488; Thermo Fisher Scientific) was identical to that of the first one and so 
were final washings. Cells were counterstained using Hoechst-33258 and mounted 
with ProLong Gold antifade reagent. For detection of active caspase-3, a similar 
protocol was used to that described for cytochrome c. A solution 1:100 of primary 
monoclonal rabbit anti-cleaved caspase-3 antibody (9664S, Cell Signaling 
Technology; Danvers, MA, USA) and 1:300 a solution of secondary antibody goat 
anti-rabbit IgG bounded to Alexa Fluor® 555 (A21428, Thermo Fisher Scientific) 
were used. 
 
1.9. Multicolour imaging 
Multicolour experiment involving the detection of LDs, microtubules and DNA: After 
incubating HeLa cells with the corresponding dye (75 nM for 1 h), the cells on 
coverslips were fixed in 4% PFA for 20 min at 4 °C, washed three times with PBS, 
and permeabilized with 0.5% Triton X-100. After 5 min, Triton X-100 was removed, 




0.02% Triton X-100 in PBS) for 15 min at R.T. Once removed the blocking solution, 
1:100 v/v solution of α-tubulin antibody (monoclonal mouse anti-α-tubulin antibody; 
Sigma Aldrich, St. Louis, MO, USA) was added to the cells and incubated at 37 °C 
for 1 h. Three 5-min washings with PBS were then carried out before addition of 
Triton X-100 for 5 min. Incubation with the secondary antibody (1:100 v/v Alexa Fluor 
488 goat anti-mouse IgG; Invitrogen) and subsequent washings were identically 
conducted to those performed with the first antibody. Finally, the cells were 
counterstained using H-33258 (Hoechst-33258; Sigma-Aldrich), mounted with 
ProLong Gold antifade reagent (Thermo Fischer Scientific) and observed by 
fluorescence microscopy.  
Multicolour experiment involving the detection of LDs, actin microfilaments and DNA: 
After incubating HeLa cells with the corresponding dye (75 nM for 1 h), the cells on 
coverslips were fixed in 4% PFA for 20 min at 4 °C, washed three times with PBS 
(5 min each), permeabilized and blocked as described above. F-actin was visualized 
by incubation with Alexa Fluor® 555 Phalloidin (Thermo Fisher Scientific) solution 
(1:200) at 37 °C in a wet chamber for 30 min. Finally, cells were washed three times 
with PBS, counterstained with Hoechst-33258 and mounted with Prolong Gold 
antifade reagent as described above. 
 
1.10. Microscopy 
Fluorescence microscopy images were acquired by using an Olympus BX63 
automated fluorescence microscope equipped with a CoolLED's pE-300 light source 
(CoolLED Ltd., Andover, UK) and an Olympus DP74 digital camera (Olympus, Center 
Valley, PA, USA). Confocal microscopy images were acquired by using a SP8 
confocal multispectral system (Leica Microsystems) with white laser (WLL2) for 
excitation, time gating hybrid detectors for fluorescence emission, HC PlanApo CS2 
63x/1.20 N.A. water objective, and zoom 0.75x. The excitation and emission 
wavelengths selected to visualize the probes were: BODIPY 2 (excitation: 488 and 
560 nm; emission: 500-540 nm and 570-648 nm for green or red images, 
respectively); BODIPY 6 (excitation: 488 nm; emission: 500-540 and 565-615 nm for 
green and red images, respectively); BODIPY 9 (excitation: 560 nm; emission: 570-
620 nm). DIC microscopy images were acquired by using the same microscope used 





2. Supplementary figures. 
 
 
Fig. S1. Different photostability of 1-9, in terms of PFEI, in ethyl acetate solution (10-3 M) after 10,000 
(white bars), 40,000 (grey bars) and 70,000 (black bars) pump pulses. PFEI is the percent laser-
induced fluorescent emission intensity in ethyl acetate solution after n pumping laser pulses, referred 
























Fig. S2. HeLa cells survival after incubating with different concentrations of 2-9 for 24 h in absence of 
light (solid bars) or including subsequent irradiation with a 10.3 J/cm2 dose of green light (518+10 nm; 
stripped bars). Cell viability was evaluated by MTT assay 24 h after the treatments. Data correspond 
to mean ± S.D. values from at least six different experiments. Statistically significant differences are 
labelled as * (p<0.001) for comparisons between groups using one-way ANOVA (all groups vs. 























Fig. S3. Differential sharp in LD bioimaging using 2-9. HeLa cells were incubated with the 
corresponding dye (5 µM for 24 h), and visualized using the blue (495/525; exposure time = 30.9 ms) 
(a-h) or green (545/620; exposure time = 400.0 ms) (a’-h’) microscope channel, to obtain green and 



















Fig. S4. Synthesis of BODIPYs 3-9. Mes: Mesityl; (PCy3)PdG2: Chloro[(tricyclohexylphosphine)-2-(2′-
aminobiphenyl)]palladium(II). 
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Fig. S5. Bioimaging using 2 (a-b), 6 (c-d) and 9 (e-f) under standard incubation conditions (a-f), or 
after treating the cells with sunflower oil before said incubation (a’-f’). The enhanced volume of the 








































Fig. S6. Subcellular co-localization experiments. A: Fluorescence bioimaging of HeLa cells showing 
the localization of BODIPY 6 by using the blue microscope channel (a), the localization of 
LysoTracker® Red (lysosome probe) by using the green microscope channel (b),  the corresponding 
merged image (c) demonstrate that no co-localization occurs between the green 6 signal (green) and 
lysosomes labeled with LysoTracker® Red. Scale bar: 5 μm. B: Fluorescence bioimaging of HeLa 
cells showing the localization of MitoTracker® Green (mitochondria probe) by using the blue 
microscope channel (note the typical morphology of the mitochondrial network), which is completely 
different from the fluorescent pattern obtained by using 6. C: HeLa cells stained with Oil Red O (ORO) 
revealing “red” LDs under bright field microscopy (a) and fluorescence microscopy (b). Note that LDs 
stained with ORO show a similar size, morphology and distribution pattern to that obtained by using 6. 
























































Fig. S7. Cellular oxidative stress detection assays. A: Qualitative characterization of ROS generation 
in the LD-9 system by DCFH-DA assay. Fluorescence images of HeLa cells after incubation with 9 in 
the dark (a) and after irradiation (b). Scale bar: 100 µm. B: Cell survival (%) of HeLa cells exposed to 9 
in presence of 5 mM NaN3 (singlet oxygen quencher) and irradiated. HeLa cells were treated with 5 
mM NaN3 for 2 h before irradiation (10.3 J/cm2). Values are the mean ± standard deviation of three 
replicate experiments. NaN3 increased the rate of cell survival (e.g., from 45% to 65 % when using 2.5 
µM 9), thus supporting the involvement of 1O2 in the PDT activity. However, since cell damage is still 

































Fig. S8. Switching apoptosis vs. necrosis by changing 6 concentration in the PDT treatment. The 
identification of the type of cell death was carried out by immnunofluorescence for two proteins 
involved in apoptosis: Cytochrome c (green) and active Caspase-3 (red). Nuclei integrity was studied 
by DNA counterstaining with Hoechst-33258 (blue). In addition, morphological changes were 
examined by phase-contrast microscopy. Untreated (control) HeLa cells showed mitochondrial 
cytochrome-c signal (a), negative expression of active caspase-3 (b), non-condensed chromatin (c), 
and characteristic HeLa cell morphology (d). HeLa cells after photodynamic treatment with 5 μM 6 
showed release of Cytochrome c from mitochondria to cytosol (f), intense red signal from activated 
Caspase-3 (g), chromatin condensation and nuclear fragmentation (h and i), cell shrinkage and 
appearance of membrane bubbles (j). The last features are typical of apoptotic death. On the other 
hand, after photodynamic treatments with 7.5 μM 6, release of cytochrome c (k) and active caspase-3 
(l) were not detected, nuclei show condensed chromatin in "patches” (m and n), and the observed 













































Fig. S9. Differential behaviour of 2 (a-c), 6 (d-f) and 9 (g-i) as nanomolar probes (cells incubated with 
75 nM dye for 1 h) for visualizing LDs in living HeLa cells using the blue (a, d and g) or green (b, e and 
h) microscope channels, and by merging the corresponding green, red and DIC images (c, f and i). No 
alteration of the cell morphology supports lack of dye cytotoxicity under the used experimental 








Fig. S10. Differential behaviour of 2 (a-c), 6 (d-f) and 9 (g-i) as nanomolar probes (cells incubated with 
75 nM dye for 1 h) for visualizing LDs in living Hs68 cells using the blue (a, d and g) or green (b, e and 
h) microscope channels, and by merging the corresponding green, red and DIC images (c, f and i). No 
alteration of the cell morphology supports lack of dye cytotoxicity under the used experimental 









































Fig. S11. Fluorescent signal remained unaltered after the fixation process of HeLa cells. A: Bioimaging 
of living cells incubated with 6 (a), 9 (b) or 2 (c), and bioimaging of the same cells after 15 min of 4% 
PFA fixation (d-f). Fluorescent detection of LDs in fixed cells was only possible by using 6 or 9. Scale 
bar 20 μm. B (up): Bioimaging of HeLa cells incubated with 6, fixed, permeabilized with Triton X-100 
and incubated with Alexa Fluor® 555 Phalloidin. LD detection using the blue microscope channel (a); 
actin-F detection using the green microscope channel (b); simultaneous detection of actin filaments, 
LDs and Hoechst-33258 counterstained nuclei by merging the corresponding images obtained by 
blue, green and UV excitation (c). B (down): Bioimaging of HeLa cells incubated with 9, fixed and 
immunolabeled for α-tubulin (microtubule detection). Microtubules detection using the blue microscope 
channel (d); LD detection using the green microscope channel (e); simultaneous detection of 
microtubules, LDs and Hoechst-33258 counterstained nuclei by merging the corresponding images 












Table S1. Fluorescence signatures of 2-9 in diluted (ca. 0.5 x 10-6 M) ethyl acetate solution. Maximum 
absorption (ab) and maximum fluorescence (fl) wavelengths, Stokes shifts () and fluorescence 
quantum yields ().  
 
BODIPY ab (nm) fl (nm)  (cm-1) 
2 a 494 504 400 0.85 
3 498 516 700 0.80 
4 510 518 303 0.77 
5 496 506 398 0.87 
6 509 519 379 0.80 
7 514 524 371 0.73 
8 525 538 460 0.70 
9 568 580 364 0.60 







4. Synthesis and characterization 
 
BODIPYs 1 and 2 (see Fig. S1 in ESI) are commercially available (laser grade; purity 
> 99%), and were used as received. 8-Mesity-3,5-dimethylBODIPY (3,8 see Fig. 1 in 
the main text), 5-chloro-1,3-dimethylBODIPY (10,9 see Fig. S5), 5-chloro-1,3,8-
trimethylBODIPY (11,9 see Fig. S5) and 3,5-dichloro-8-mesitylBODIPY (12,10 see Fig. 
S5) were synthesized by the corresponding described methods. 
 
4.1. General procedure for Negishi reactions  
The corresponding haloBODIPY (0.10-0.35 mmol), PdCl2(PPh3)2 (10 mol%) and dry 
toluene (2 mL) were placed into a Schlenk tube capped with a rubber septum, under 
argon atmosphere. This tube was previously air-evacuated and backfilled with argon 
(this sequence is repeated three times). Then, the corresponding organozinc reagent 
(0.26-1.75 mmol) was drop-wised added over the mixture and the resulting reaction 
mixture stirred at r.t. for 1-6 h. The reaction progress was monitored by thick layer 
chromatography (TLC) on silica gel. Once the reaction was monitored as finalized, 
the mixture was filtered (CH2Cl2 was used for elution and washing), and the obtained 
solution submitted to solvent evaporation under vacuum. The obtained residue was 
purified by flash chromatography on silica gel. 
 
4.2. Synthesis of 4 
According to above described general procedure for Negishi reactions, 109 (40 mg, 
0.16 mmol), PdCl2(PPh3)2 (11 mg, 0.016 mmol) and 0.5 M BrZn(CH2)5COOEt in THF 
(1.9 mL, 0.95 mmol) in dry toluene (2 mL) were reacted for 3 h. Flash 
chromatography using hexane/EtOAc (98:2) afforded 4 (50 mg, 86%) as a brown 
solid. 1H NMR (700 MHz, CDCl3)  7.06 (s, 1H, CH), 6.90 (d, J = 4.2 Hz, 1H, CH), 
6.27 (d, J = 4.2 Hz, 1H, CH), 6.09 (s, 1H, CH), 4.12 (q, J = 7.0 Hz, 2H, CH2O), 2.97 (t, 
J = 7.7 Hz, 2H, CH2), 2.55 (s, 3H, CH3), 2.31 (t, J = 7.7 Hz, 2H, CH2), 2.24 (s, 3H, 
CH3), 1.75 (quint, J = 7.7 Hz, 2H, CH2), 1.69 (quint, J = 7.7 Hz, 2H, CH2), 1.46 (quint, 
J = 7.7 Hz, 2H, CH2), 1.25 (t, J = 7.0 Hz, 3H, CH3) ppm; 13C NMR (176 MHz, CDCl3) 
 173.8 (COO), 160.3 (C), 159.2 (C), 143.0 (C), 134.7 (C), 133.3 (C), 128.4 (CH), 
123.5 (CH), 120.0 (CH), 116.8 (CH), 60.2 (CH2O), 34.3 (CH2), 29.0 (CH2), 28.5 (CH2), 




1723, 1570, 1311, 1145, 986 cm-1; HRMS-EI m/z 362.1969 (362.1977 calcd for 
C19H25BF2N2O2). 
 
4.3. Synthesis of 5 
According to above described general procedure for Negishi reactions, 119 (93 mg, 
0.35 mmol), PdCl2(PPh3)2 (24.6 mg, 0.035 mmol) in dry toluene (2 mL) and 0.5 M 
BrZn(CH2)5CO2Et in THF (3.5 mL, 1.75 mmol) were reacted for 6 h. Flash 
chromatography using hexane/CH2Cl2 (5:5) afforded unaltered 11 (12 mg, 15%), and 
5 (80 mg, 61%) as a brown solid. 1H NMR (700 MHz, CDCl3)  7.09 (d, J = 4.2 Hz, 
1H, CH), 6.26 (d, J = 4.2 Hz, 1H, CH), 6.08 (s, 1H, CH), 4.12 (q, J = 7.0 Hz, 2H, 
CH2O), 2.96 (t, J = 7.7 Hz, 2H, CH2), 2.54 (s, 3H, CH3), 2.50 (s, 3H, CH3), 2.38 (s, 3H, 
CH3), 2.30 (t, J = 7.7 Hz, 2H, CH2), 1.74 (quint, J = 7.7 Hz, 2H, CH2), 1.69 (quint, J = 
7.7 Hz, 2H, CH2), 1.45 (quint, J = 7.7 Hz, 2H, CH2), 1.25 (t, J = 7.0 Hz, 3H, CH3) 
ppm; 13C NMR (176 MHz, CDCl3)  173.8 (COO), 158.7 (C), 156.5 (C), 142.7 (C), 
140.4 (C), 134.3 (C), 132.7 (C), 125.7 (CH), 121.7 (CH), 115.9 (CH), 60.2 (CH2O), 
34.3 (CH2), 29.0 (CH2), 28.4 (CH2), 28.3 (CH2), 24.8 (CH2), 16.6 (CH3), 16.4 (CH3), 
14.7 (CH3), 14.3 (CH3) ppm; FTIR  2926, 2857, 1730, 1561, 1301, 1150, 987 cm-1; 
HRMS-EI m/z 376.2130 (376.2134 calcd for C20H27BF2N2O2). 
 
4.4. Synthesis of 13 
According to above described general procedure for Negishi reactions, 1210 (50 mg, 
0.13 mmol), PdCl2(PPh3)2 (9 mg, 0.013 mmol) and 0.5 M BrZn(CH2)5COOEt in THF 
(1 mL, 0.528 mmol) in dry toluene (2 mL) were reacted for 1.5 h. Flash 
chromatography using hexane/EtOAc (95:5) afforded unaltered 12 (15 mg, 30%), 
and 13 (40 mg, 62%) as a brown solid. 1H NMR (700 MHz, CDCl3)  6.93 (s, 2H, 
2CH), 6.62 (d, J = 4.2 Hz, 1H, CH), 6.44 (d, J = 4.2 Hz, 1H, CH), 6.36 (d, J = 4.2 Hz, 
1H, CH), 6.26 (d, J = 4.2 Hz, 1H, CH), 4.12 (q, J = 7.0 Hz, 2H, CH2O), 3.07 (t, J = 7.7 
Hz, 2H, CH2), 2.34 (s, 3H, CH3), 2.32 (t, J = 7.7 Hz, 2H, CH2), 2.09 (s, 6H, 2CH3), 
1.79 (quint, J = 7.7 Hz, 2H, CH2), 1.70 (quint, J = 7.7 Hz, 2H, CH2), 1.49 (quint, J = 
7.7 Hz, 2H, CH2), 1.25 (t, J = 7.0 Hz, 3H, CH3) ppm; 13C NMR (176 MHz, CDCl3)  
173.7 (COO), 166.3 (C), 142.9 (C), 140.2 (C), 138.8 (C), 136.6 (C), 135.6 (C), 133.0 
(C), 131.5 (CH), 129.1 (C), 128.2 (CH), 127.4 (CH), 120.0 (CH), 116.8 (CH), 60.3 




(CH3), 14.3 (CH3) ppm; FTIR  2928, 2862, 1730, 1562, 1408, 1329, 1267, 1102, 
1045, 970 cm-1; HRMS-EI m/z 486.2051 (486.2057 calcd for C26H30BClF2N2O2). 
 
4.5. Synthesis of 6 
According to above described general procedure for Negishi reactions, 13 (52 mg, 
0.11 mmol), PdCl2(PPh3)2 (8 mg, 0.011 mmol) and 1.2 M ZnMe2 in toluene (0.22 mL, 
0.265 mmol) in dry toluene (2 mL) were reacted for 1 h. Flash chromatography using 
hexane/EtOAc (95:5) afforded 6 (37 mg, 75%) as a brown solid. 1H NMR (300 MHz, 
CDCl3)  6.92 (s, 2H, 2CH), 6.48 (d, J = 4.2 Hz, 1H, CH), 6.46 (d, J = 4.2 Hz, 1H, CH), 
6.24 (d, J = 4.2 Hz, 1H, CH), 6.19 (d, J = 4.2 Hz, 1H, CH), 4.12 (q, J = 7.2 Hz, 2H, 
CH2O), 3.03 (t, J = 7.8 Hz, 2H, CH2), 2.63 (s, 3H, CH3), 2.34 (s, 3H, CH3), 2.32 (t, J = 
7.5 Hz, 2H, CH2), 2.09 (s, 6H, 2CH3), 1.83-1.66 (m, 4H, 2CH2), 1.54-1.44 (m, 2H, 
CH2), 1.25 (t, J = 7.2 Hz, 3H, CH3) ppm; 13C NMR (75 MHz, CDCl3)  173.7 (COO), 
162.0 (C), 157.5 (C), 142.4 (C), 138.3 (C), 136.6 (C), 134.7 (C), 134.5 (C), 130.1 (C), 
129.0 (CH), 128.9 (CH), 128.0 (CH), 119.3 (CH), 117.6 (CH), 60.2 (CH2O), 34.3 
(CH2), 29.1 (CH2), 28.7 (CH2), 28.2 (CH2), 24.8 (CH2), 21.1 (CH3), 20.0 (CH3), 14.9 
(CH3), 14.3 (CH3) ppm; FTIR  2926, 2860, 1733, 1560, 1272, 1142, 1125, 1089, 999 
cm-1; HRMS-EI m/z 466.2597 (466.2603 calcd for C27H33BF2N2O2). 
 
4.6. Synthesis of 14 
According to above described general procedure for Negishi reactions, 1210 (50 mg, 
0.13 mmol), PdCl2(PPh3)2 (9 mg, 0.013 mmol) and 0.5 M BrZn(CH2)3COOEt in THF 
(0.78 mL, 0.39 mmol) in dry toluene (2 mL) were reacted for 1 h. Flash 
chromatography using hexane/EtOAc (98:2) afforded unaltered 12 (7 mg, 14%), and 
14 (39 mg, 65%) as an orange solid. 1H NMR (700 MHz, CDCl3)  6.93 (s, 2H, 2CH), 
6.62 (d, J = 4.2 Hz, 1H, CH), 6.46 (d, J = 4.2 Hz, 1H, CH), 6.39 (d, J = 4.2 Hz, 1H, 
CH), 6.27 (d, J = 4.2 Hz, 1H, CH), 4.14 (q, J = 7.0 Hz, 2H, CH2O), 3.11 (t, J = 7.7 Hz, 
2H, CH2), 2.45 (t, J = 7.7 Hz, 2H, CH2), 2.34 (s, 3H, CH3), 2.11 (quint, J = 7.7 Hz, 2H, 
CH2), 2.09 (s, 6H, 2CH3), 1.26 (t, J = 7.0 Hz, 3H, CH3) ppm; 13C NMR (176 MHz, 
CDCl3)  173.1 (COO), 164.9 (C), 143.3 (C), 140.7 (C), 138.8 (C), 136.6 (C), 135.6 
(C), 133.2 (C), 131.5 (CH), 129.0 (C), 128.2 (CH), 127.8 (CH), 119.9 (CH), 117.1 
(CH), 60.5 (CH2O), 33.8 (CH2), 28.3 (CH2), 23.7 (CH2), 21.1 (CH3), 20.0 (CH3), 14.2 




1111, 1048, 993, 973 cm-1; HRMS-EI m/z 458.1738 (458.1744 calcd. for 
C24H26BClF2N2O2). 
 
4.7. Synthesis of 7 
According to above described general procedure for Negishi reactions, 14 (46 mg, 
0.10 mmol), PdCl2(PPh3)2 (7 mg, 0.010 mmol) and 1.2 M ZnMe2 in toluene (0.5 mL, 
0.5 mmol) in dry toluene (2 mL) were reacted for 4 h. Flash chromatography using 
hexane/Et2O (98:2) afforded 7 (30 mg, 67%) as an orange solid, and unaltered 14 
(13 mg, 28%). 1H NMR (300 MHz, CDCl3)  6.92 (s, 2H, 2CH), 6.48 (d, J = 4.2 Hz, 
2H, 2CH), 6.27 (d, J = 4.2 Hz, 1H, CH), 6.20 (d, J = 4.2 Hz, 1H, CH), 4.15 (q, J = 7.2 
Hz, 2H, CH2O), 3.07 (t, J = 7.8 Hz, 2H, CH2), 2.63 (s, 3H, CH3), 2.45 (t, J = 7.8 Hz, 
2H, CH2), 2.34 (s, 3H, CH3), 2.15-2.05 (m, 8H, CH2 and 2CH3), 1.27 (t, J = 7.2 Hz, 
3H, CH3) ppm; 13C NMR (75 MHz, CDCl3)  173.3 (COO), 160.5 (C), 158.0 (C), 
142.7 (C), 138.4 (C), 136.6 (C), 134.8 (C), 134.4 (C), 130.1 (C), 129.3 (CH), 128.9 
(CH), 128.0 (CH), 119.7 (CH), 117.6 (CH), 60.4 (CH2O), 34.0 (CH2), 28.1 (CH2), 23.8 
(CH2), 21.1 (CH3), 20.0 (CH3), 15.0 (CH3), 14.3 (CH3) ppm; FTIR  2925, 2855, 1735, 
1564, 1439, 1274, 1132, 1011 cm-1; HRMS-EI m/z 438.2285 (438.2290 calcd for 
C25H29BF2N2O2). 
 
4.8. Synthesis of 8 
To a solution of methyl 6-chloro-6-oxohexanoate* (175 mg, 0.97 mmol) in CH2Cl2 (15 
mL) was added, under argon atmosphere, 3-ethyl-2,4-dimethylpyrrole (0.33 mL, 2.44 
mmol), and the mixture was refluxed for 3 h. After cooling down to r.t., Et3N (0.7 mL, 
4.88 mmol) and BF3·Et2O (0.6 mL, 4.88 mmol) were added, and stirring maintened 
for 2 h. Finally, the solvent was removed by vacuum distillation, and the obtained 
residue solved in EtOAc. The obtained solution was washed with 10% aq HCl and 
H2O. The organic layer was dried over Na2SO4, filtered and concentrated to dryness. 
The crude product was purified by flash chromatography, using silica gel and 
hexane/CHCl3 (95:5), to afford 8 (120 mg, 30%) as an orange solid. 1H NMR (300 
MHz, CDCl3)  3.67 (s, 3H, CH3O), 3.03-2.98 (m, 2H, CH2), 2.49 (s, 6H, 2CH3), 2.40 
(t, J = 7.2 Hz, 2H, CH2), 2.40 (q, J = 7.5 Hz, 4H, 2CH2), 2.33 (s, 6H, 2CH3), 1.88-1.78 
(m, 2H, CH2), 1.72-1.63 (m, 2H, CH2), 1.04 (t, J = 7.5 Hz, 6H, 2CH3) ppm; 13C NMR 
(75 MHz, CDCl3)  173.7 (COO), 152.2 (C), 144.0 (C), 135.6 (C), 132.7 (C), 130.9 




(CH3), 13.3 (CH3), 12.4 (CH3) ppm. FTIR  2925, 2855, 1741, 1548, 1472, 1331, 
1264, 1198, 1071, 982 cm-1; HRMS-EI m/z 418.3356 (418.3358 calcd for 
C23H33BF2N2O2). 
*Synthesis of methyl 6-chloro-6-oxohexanoate: To a solution of 6-methoxy-6-
oxohexanoic acid (0.012 mL, 0.11 mmol) in CH2Cl2 (2 mL) was added, under argon 
atmosphere, tionyl chloride (0.035 mL, 0.44 mmol), and the mixture was refluxed for 
20 min. Then, the excess of tionyl chloride and the solvent were removed by vacuum 
distillation. The product was used without further purification. 
 
4.9. Synthesis of 9 
Chloro[(tricyclohexylphosphine)-2-(2′-aminobiphenyl)]palladium(II) ((PCy3)PdG2; 1 
mg, 0.002 mmol), 1 M Na2CO3 in H2O (1 mL) and 2-thienylboronic acid (17 mg, 0.132 
mmol) were added to a solution of 13 (21 mg, 0.044 mmol) in dry toluene (3 mL) 
under argon atmosphere, and the mixture stirred at 100 ºC for 4.5 h. The reaction 
progress was monitored by TLC. Once the reaction was tested as completed by TLC, 
the mixture was filtered (CH2Cl2 is used for elution and washing), and the obtained 
organic layer washed with H2O, dried over MgSO4, filtered and submitted to solvent 
evaporation under vacuum. Flash chromatography using hexane/CH2Cl2 (8:2) 
afforded 9 (12 mg, 50%) as a purple solid, and unaltered 13 (5 mg, 23%). 1H NMR 
(700 MHz, CDCl3)  8.14 (d, J = 3.5 Hz, 1H, CH), 7.45 (d, J = 4.9 Hz, 1H, CH), 7.18 
(apparent t, J = 4.2 Hz, 1H, CH), 6.94 (s, 2H, 2CH), 6.67 (d, J = 4.2 Hz, 1H, CH), 
6.53 (d, J = 4.2 Hz, 1H, CH), 6.51 (d, J = 4.9 Hz, 1H, CH), 6.31 (d, J = 4.2 Hz, 1H, 
CH), 4.12 (q, J = 7.0 Hz, 2H, CH2O), 3.09 (t, J = 7.7 Hz, 2H, CH2), 2.36 (s, 3H, CH3), 
2.35 (t, J = 7.0 Hz, 2H, CH2), 2.12 (s, 6H, 2CH3), 1.79 (quint, J = 7.7 Hz, 2H, 2CH2), 
1.71 (quint, J = 7.7 Hz, 2H, CH2), 1.50 (quint, J = 7.7 Hz, 2H, CH2), 1.25 (t, J = 7.0 Hz, 
3H, CH3) ppm; 13C NMR (176 MHz, CDCl3)  173.8 (COO), 163.2 (C), 149.3 (C), 
141.8 (C), 138.4 (C), 136.8 (C), 136.3 (C), 134.9 (C), 134.4 (C), 130.5 (CH), 130.2 
(C), 129.2 (CH), 128.9 (CH), 128.6 (CH), 128.5 (CH), 128.1 (CH), 119.6 (CH), 118.7 
(CH), 60.2 (CH2O), 34.2 (CH2), 29.1 (CH2), 28.8 (CH2), 28.1 (CH2), 24.8 (CH2), 21.1 
(CH3), 20.0 (CH3), 14.3 (CH3) ppm; FTIR  2925, 2855, 1734, 1570, 1465, 1372, 







5. 1H NMR and 13C NMR spectra 
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